首页|结直肠癌蛋白质组学分析及其应用

结直肠癌蛋白质组学分析及其应用

扫码查看
目的 基于 LC-MS/MS非标记定量蛋白质组学分析结直肠癌(colorectal cancer,CRC)差异蛋白并筛选与 CRC 发生相关的关键通路.方法 采用LC-MS/MS对 3 例CRC患者肿瘤组织和癌旁正常组织的蛋白质组进行定量分析,筛选差异蛋白.通过生物信息学分析筛选与 CRC发生发展密切相关的候选蛋白并验证.通过 TCGA分析筛选 CRC潜在标志物.结果 蛋白质组学分析共鉴定了 4 257 个蛋白,差异蛋白 544 个,显著上调蛋白 446 个,显著下调蛋白 98 个.基于GO富集分析及KEGG通路分析,发现与RNA和 DNA功能相关的蛋白通过调控基因表达和细胞增殖参与了 CRC的发生发展.基于此筛选 RNA 功能相关差异蛋白为候选蛋白:PRPF19、HNRNPM、UTP18、RCL1、RPL3、EIF5、NCBP2、NOP58、RANBP2,随后在另外 5 例 CRC 患者肿瘤组织和癌旁组织上进行了表达验证.成功验证出 NCBP2、PRPF19、HNRNPM 在 CRC中表达显著增加,且 NCBP2 表达水平与患者总体生存率呈负相关.结论 本研究筛选了在 CRC发生发展过程中具有潜在重要作用的 3 个差异蛋白,有望作为 CRC诊断和治疗的靶标.
Proteomic analysis of colorectal cancer and its application
Objective To analyze different proteins in colorectal cancer(CRC)by LC-MS/MS and further screen underling mechanisms related to CRC.Methods LC-MS/MS was used to quantitatively analyze the proteomes of tumor tissues and adjacent normal tissues from 3 CRC patients.Candidate proteins closely related to the occurrence and devel-opment of CRC were screened and verified by bioinformatics analysis.Screening of potential biomarkers of CRC by TCGA analysis.Results A total of 4 257 proteins were identified,including 544 differential proteins,of which 446 were significantly up-regulated and 98 were significantly down-regulated.Based on GO enrichment analysis and KEGG pathway analysis,it was found that proteins related to RNA and DNA functions were involved in the occurrence and de-velopment of CRC by regulating gene expression and cell proliferation.Based on this,the differential proteins related to RNA function were screened as candidate proteins,including PRPF19,HNRNPM,UTP18,RCL1,RPL3,EIF5,NCBP2,NOP58,RANBP2,and their expression was verified in five other CRC patients.It was successfully verified that the expression of proteins NCBP2,PRPF19 and HNRNPM was significantly increased in CRC,and the expression level of NCBP2 was negatively correlated with the overall survival rate of patients.Conclusion This study screened 3 differential proteins with potentially important roles in the occurrence and development of CRC,which are expected to be targets for the diagnosis and treatment of CRC.

Quantitative proteomicsColorectal cancerBiomarkerNCBP2

贾振宇、钱丽娟、夏婷婷

展开 >

苏州大学附属第一医院消化内科,江苏 苏州 215006

定量蛋白质组学 结直肠癌 生物标志物 NCBP2

2024

胃肠病学和肝病学杂志
郑州大学

胃肠病学和肝病学杂志

CSTPCD
影响因子:1.029
ISSN:1006-5709
年,卷(期):2024.33(10)
  • 1